Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Case Western Reserve University at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Case Western Reserve University brings 1 presentation to SITC 2026 in Phoenix. Its program focuses on human ex vivo models for testing immunotherapy, with bioinformatics, big data and AI alongside. The most concrete topic is using organoids grown from patients' brain tumors to study and overcome myeloid immune suppression.

OrganizationSITC 2026 Attendance
Universities & research institutes
Private research university in Cleveland with a school of medicine.
Session
Thu Nov 5
12:00pm–1:30pm
Session
Fri Nov 6
1:45pm–3:25pm
Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip
Models & tech
  1. 2:00pm–2:15pmPatient-Derived Brain Tumor Organoids to Model and Overcome Myeloid ImmunosuppressionCase Western Reserve University
  2. 2:15pm–2:30pmPersonalizing Cancer Immunotherapy Using Patient-Derived Tumor ModelsNetherlands Cancer Institute
  3. 2:30pm–2:45pmDynamic Immune Profiling Using Human Ex Vivo Tumor ModelsDana-Farber Cancer Institute
  4. 2:45pm–3:00pmFrom Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety AssessmentU.S. Food and Drug Administration
  5. 3:00pm–3:20pm2 abstract presentations — titles not yet released

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Case Western Reserve University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction